166 related articles for article (PubMed ID: 22665596)
1. Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances.
Deye GA; Gettayacamin M; Hansukjariya P; Im-erbsin R; Sattabongkot J; Rothstein Y; Macareo L; Fracisco S; Bennett K; Magill AJ; Ohrt C
Am J Trop Med Hyg; 2012 Jun; 86(6):931-5. PubMed ID: 22665596
[TBL] [Abstract][Full Text] [Related]
2. KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro.
Zeeman AM; van Amsterdam SM; McNamara CW; Voorberg-van der Wel A; Klooster EJ; van den Berg A; Remarque EJ; Plouffe DM; van Gemert GJ; Luty A; Sauerwein R; Gagaring K; Borboa R; Chen Z; Kuhen K; Glynne RJ; Chatterjee AK; Nagle A; Roland J; Winzeler EA; Leroy D; Campo B; Diagana TT; Yeung BK; Thomas AW; Kocken CH
Antimicrob Agents Chemother; 2014; 58(3):1586-95. PubMed ID: 24366744
[TBL] [Abstract][Full Text] [Related]
3. Triangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapse.
Macareo L; Lwin KM; Cheah PY; Yuentrakul P; Miller RS; Nosten F
Malar J; 2013 May; 12():173. PubMed ID: 23718705
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).
Saunders D; Vanachayangkul P; Imerbsin R; Khemawoot P; Siripokasupkul R; Tekwani BL; Sampath A; Nanayakkara NP; Ohrt C; Lanteri C; Gettyacamin M; Teja-Isavadharm P; Walker L
Antimicrob Agents Chemother; 2014 Dec; 58(12):7283-91. PubMed ID: 25267666
[TBL] [Abstract][Full Text] [Related]
5. Anti-relapse activity of mirincamycin in the Plasmodium cynomolgi sporozoite-infected Rhesus monkey model.
Fracisco S; Teja-isavadharm P; Gettayacamin M; Berman J; Li Q; Melendez V; Saunders D; Xie L; Ohrt C
Malar J; 2014 Oct; 13():409. PubMed ID: 25326032
[TBL] [Abstract][Full Text] [Related]
6. Imported tertian malaria resistant to primaquine.
Na DJ; Han JD; Cha DY; Song IK; Choi HW; Chung EA; Park CW; Choi JS
Korean J Intern Med; 1999 Jul; 14(2):86-9. PubMed ID: 10461431
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
[TBL] [Abstract][Full Text] [Related]
8. Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
DiTusa C; Kozar MP; Pybus B; Sousa J; Berman J; Gettayacamin M; Im-erbsin R; Tungtaeng A; Ohrt C
J Parasitol; 2014 Oct; 100(5):671-3. PubMed ID: 24780070
[TBL] [Abstract][Full Text] [Related]
9. Safety, Pharmacokinetics, and Activity of High-Dose Ivermectin and Chloroquine against the Liver Stage of Plasmodium cynomolgi Infection in Rhesus Macaques.
Vanachayangkul P; Im-Erbsin R; Tungtaeng A; Kodchakorn C; Roth A; Adams J; Chaisatit C; Saingam P; Sciotti RJ; Reichard GA; Nolan CK; Pybus BS; Black CC; Lugo-Roman LA; Wegner MD; Smith PL; Wojnarski M; Vesely BA; Kobylinski KC
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32660993
[TBL] [Abstract][Full Text] [Related]
10. PI4 Kinase Is a Prophylactic but Not Radical Curative Target in Plasmodium vivax-Type Malaria Parasites.
Zeeman AM; Lakshminarayana SB; van der Werff N; Klooster EJ; Voorberg-van der Wel A; Kondreddi RR; Bodenreider C; Simon O; Sauerwein R; Yeung BK; Diagana TT; Kocken CH
Antimicrob Agents Chemother; 2016 May; 60(5):2858-63. PubMed ID: 26926645
[TBL] [Abstract][Full Text] [Related]
11. Causal prophylactic and radical curative activity of WR182393 (a guanylhydrazone) against Plasmodium cynomolgi in Macaca mulatta.
Corcoran KD; Hansukjariya P; Sattabongkot J; Ngampochjana M; Edstein MD; Smith CD; Shanks GD; Milhous WK
Am J Trop Med Hyg; 1993 Oct; 49(4):473-7. PubMed ID: 8214277
[TBL] [Abstract][Full Text] [Related]
12. [Two imported and relapsed of Plasmodium vivax malaria cases and primaquine prophylaxis].
Hatipoğlu M; Ulçay A; Turhan V; Karagöz E; Erdem H; Acar A; Oncül O; Görenek L
Turkiye Parazitol Derg; 2014 Jun; 38(2):120-3. PubMed ID: 25016120
[TBL] [Abstract][Full Text] [Related]
13. Humoral immunity prevents clinical malaria during Plasmodium relapses without eliminating gametocytes.
Joyner CJ; Brito CFA; Saney CL; Joice Cordy R; Smith ML; Lapp SA; Cabrera-Mora M; Kyu S; Lackman N; Nural MV; DeBarry JD; ; Kissinger JC; Styczynski MP; Lee FE; Lamb TJ; Galinski MR
PLoS Pathog; 2019 Sep; 15(9):e1007974. PubMed ID: 31536608
[TBL] [Abstract][Full Text] [Related]
14. Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo.
Adekunle AI; Pinkevych M; McGready R; Luxemburger C; White LJ; Nosten F; Cromer D; Davenport MP
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003595. PubMed ID: 25780913
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
Puri SK; Singh N
Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
[TBL] [Abstract][Full Text] [Related]
16. Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.
He X; Pan M; Zeng W; Zou C; Pi L; Qin Y; Zhao L; Qin P; Lu Y; Baird JK; Huang Y; Cui L; Yang Z
BMC Infect Dis; 2019 Aug; 19(1):704. PubMed ID: 31399061
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of primaquine glyco-conjugates as potential tissue schizontocidal antimalarial agents.
Azad CS; Saxena M; Siddiqui AJ; Bhardwaj J; Puri SK; Dutta GP; Anand N; Saxena AK
Chem Biol Drug Des; 2017 Aug; 90(2):254-261. PubMed ID: 28102941
[TBL] [Abstract][Full Text] [Related]
18. Development of an effective alternative model for in vivo hypnozoite-induced relapse infection: A Japanese macaque (Macaca fuscata) model experimentally infected with Plasmodium cynomolgi.
Kawai S; Annoura T; Araki T; Shiogama Y; Soma S; Takano JI; Sato MO; Kaneko O; Yasutomi Y; Chigusa Y
Parasitol Int; 2020 Jun; 76():102096. PubMed ID: 32114084
[TBL] [Abstract][Full Text] [Related]
19. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
[TBL] [Abstract][Full Text] [Related]
20. Contrasting infection susceptibility of the Japanese macaques and cynomolgus macaques to closely related malaria parasites, Plasmodium vivax and Plasmodium cynomolgi.
Tachibana S; Kawai S; Katakai Y; Takahashi H; Nakade T; Yasutomi Y; Horii T; Tanabe K
Parasitol Int; 2015 Jun; 64(3):274-81. PubMed ID: 25316604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
